Genentech, a subsidiary of Roche, has released mixed results from phase 3 trials of its biologic astegolimab for treating chronic obstructive pulmo...
Minaris Advanced Therapies has announced the appointment of Dr. Orla Cloak as its new Chief Executive Officer. Dr. Cloak brings over 20 years of ex...
Novatae Risk Group, based in Dallas, Texas, has appointed Anju Arora to the newly established position of vice president of data, business intellig...
Eisai Inc. is set to present four-year efficacy and safety data on its Alzheimer's treatment, lecanemab, at the Alzheimer's Association Internation...
Latent Labs has introduced a web-based AI model, LatentX, designed to democratize protein design. This model allows users to create novel proteins,...
Sarepta Therapeutics has announced a halt in shipments of its gene therapy, Elevidys, designed for Duchenne muscular dystrophy. This decision comes...
Recent studies have raised concerns about the potential link between common medications and an increased risk of dementia, particularly in older ad...
Cycle Pharmaceuticals has announced an exclusive partnership with LeMed Specialty Pharmacy for the distribution and services of HARLIKU™ (nitisinon...
Sarepta Therapeutics is under scrutiny for refusing the FDA's request to halt shipments of its gene therapy, Elevidys, following patient deaths lin...
The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr. George Tidmarsh is the founder and...